Now in its seventh successful year and relocating to a new venue in London, UK, Pharma Integrates will take place this year on 12–13 November at the Grange Tower Bridge Hotel.

Hoping to exceed the excellent industry presence of more than 90 prestigious speakers and 350 senior industry executives in 2017, the upcoming event will remain true to the key value chain themes of sourcing and financing innovation, improving access to medicines, optimizing pharma R&D, patient engagement and supply chain management.

Digging deeper into the core content, a top-tier programme of interviews and interactive debates will focus on some of the strategic issues facing the drug manufacturing sector. Topics for debate include the rise of AI and machine learning, patent issues, reputation management, improving the patient experience and “designing digital” into pharma.

Topics already tabled for discussion range from changing pharma’s focus from treatment to prevention, the impact of medtech wearables, developments in cell and gene therapy, surgically removing the industry’s “anticollaboration gene” and, perhaps most contentiously, tackling the thorny matter of “trust.” And, with representation from the entire pharma community, including biotechs, SMEs, small to large pharma companies, CROs, CDMOs, consultants, patient groups and academics, this not-to-be-missed meeting also offers unparalleled networking opportunities.

For the detailed agenda and to register, visit Pharma Integrates.